This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2024!
March 11-14, 2024Town and Country Resort, San Diego
Mark Your Calendar for BPI US West 2024!
March 11-14, 2024,
Town and Country Resort, San Diego

Cell & Gene Therapy Manufacturing Track

Access ground breaking bioprocessing, manufacturing & supply chain strategies to revolutionize your cell, gene and CAR-T clinical and late stage programs. Learn about today's ground-breaking bioprocessing, manufacturing, supply chain and analytical strategies to increase efficiencies in the scale up of your cell, gene & gene edited ex vivo cell therapy programs.

The learning continues with us long after the conference ends...

Did you know that your pass would allow you access to ALL of our conference tracks? You will also receive 12 months of access to the presentation recordings across all tracks.

Access Key Industry Updates & Scientific Insights Across the Cell & Gene Therapy Spectrum

Join companies like Sarepta Therapeutics, Ultragenyx Pharmaceutical Inc., PTC Therapeutics, Biogen, Bristol Myers Squibb, Sanofi, Novartis, Novartis Gene Therapies, Ultragenyx Gene Therapy, and CSL Behring.

Cell Line Development & Upstream Process Development Strategies - Increasing Yields and Process Productivity

  • Innovations to Cell Line Developing to Increase Product Yield
  • Applications of Producer Cell Lines to Aid with Scale Up of Gene Therapy Production
  • Improving Efficiency for Upstream Process Development within Gene Therapies

Downstream Processing, Viral Clearance, and Formulation Strategies

  • Overcome Bottlenecks in Downstream Processing with Novel Technologies
  • Exploring Formulation Strategies to Increase Storage Stability for your CGTs
  • Meeting Regulatory Guidelines and Expectations with Viral Clearance Approaches

Cell and Gene Therapy Analytics: Developing and Validating Novel Analytical Technologies for Product and Process Characterisation & Validation

  • Manufacturing Process & Product Development Efforts
  • Process Validation and CPV for Cell and Gene Therapy
  • Creation of Fit-for Purpose Devices and an All-in-One Automated Platform 

Gene Therapy – Scale Up and Manufacturing Strategies

  • Large scale gene modification
  • Strategizing an economically viable manufacturing journey
  • Instrumentation and mechanisms to drive efficient therapies